Lymphocyte function-associated-antigen-1 (LFA-1) is able to bind selec
tively to its ligands intercellular adhesion molecules 1 and 3 (ICAM-1
and ICAM-3), suggesting that LFA-1 can exist in distinct ligand-speci
fic binding states. In the case of ICAM-1, apart from ligand itself an
d the recently cloned molecule cytohesin-1, the natural physiological
regulators of LFA-l-mediated binding to ICAM-1 are unknown. We have in
vestigated the role of ligands (ICAM-1 and ICAM-3) in LFA-1 activation
by using ICAM-blocking monoclonal antibodies and a fixation protocol
for ''freezing'' LFA-1 on the surface of cells after prior exposure to
ICAM-1 and ICAM-3. These studies not only confirm that LFA-1 exists i
n distinct ICAM-specific activation states, but also demonstrate that
ICAM-1 plays a role in the activation of LFA-1 binding to ICAM-3.